Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | VP-Corporate Controller | March 01, 2024 | March 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date March 01, 2024 · Filed March 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $79.95 · Expires 2034-03-01 | Direct | 8,000 |
Reported balance
After 2024-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-01 · Grant · Acquired 8,000 · Balance 8,000 F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2024 Filed Mar 5, 2024 20:56 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008488 · form4.xml · derivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,100 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · derivative · entry 12 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,100 Underlying: Common Stock · 5,100 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · derivative · entry 11 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,700 Underlying: Common Stock · 5,400 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · derivative · entry 10 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,400 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,800 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · derivative · entry 9 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,800 shares Expires 2031-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,100 | $126.65 | $645,915.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 8 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,004 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.54 to $126.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,400 | $126.42 | $682,668.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 7 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,104 Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,400 | $126.78 | $684,612.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 6 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,504 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.60 to $127.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,800 | $127.44 | $356,832.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 5 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,904 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.25 to $127.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,100 | $97.69 | $498,219.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,400 | $78.76 | $425,304.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,400 | $59.96 | $323,784.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,800 | $41.93 | $117,404.00 |
DisclosureSEC source: 0001127602-23-014082 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:06 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008902 · form4.xml · derivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:32 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008070 · form4.xml · derivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $122.55 | $0.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · derivative · entry 16 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-03-01 F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,550 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · derivative · entry 15 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 2,550 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · derivative · entry 14 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Underlying: Common Stock · 5,400 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,700 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · derivative · entry 13 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 2,700 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,800 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · derivative · entry 12 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Stock · 2,800 shares Expires 2031-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,860 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · derivative · entry 11 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,860 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,550 | $122.50 | $312,375.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 10 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,550 | $97.69 | $249,109.50 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 9 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,400 | $122.50 | $661,500.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 8 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,400 | $78.76 | $425,304.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 7 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,700 | $122.50 | $330,750.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 6 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,700 | $59.96 | $161,892.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 5 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,800 | $122.53 | $343,074.76 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $122.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,800 | $41.93 | $117,404.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,860 | $122.77 | $473,902.62 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.66 to $122.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 3,860 | $39.87 | $153,898.20 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-20-031074 · form4.xml · derivative · entry 6 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Underlying: Common Stock · 5,400 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 807 | $101.47 | $81,886.29 |
DisclosureSEC source: 0001127602-20-031074 · form4.xml · nonDerivative · entry 5 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.06 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,593 | $100.39 | $461,077.49 |
DisclosureSEC source: 0001127602-20-031074 · form4.xml · nonDerivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,811 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,400 | $59.96 | $323,784.00 |
DisclosureSEC source: 0001127602-20-031074 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,038 | $101.43 | $206,714.34 |
DisclosureSEC source: 0001127602-20-031074 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.04 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,870 | $100.64 | $288,836.80 |
DisclosureSEC source: 0001127602-20-031074 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,042 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,050 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · derivative · entry 8 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 Underlying: Common Stock · 5,050 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,050 | $103.00 | $520,150.00 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · nonDerivative · entry 6 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,912 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,050 | $41.93 | $211,746.50 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · nonDerivative · entry 5 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,939 | $103.00 | $302,717.00 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · nonDerivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,912 Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,350 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · derivative · entry 7 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,650 Underlying: Common Stock · 3,350 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,350 | $103.40 | $346,397.37 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,851 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.26 to $103.51. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 3,350 | $41.93 | $140,465.50 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 22:30 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,061 | $103.36 | $213,024.96 |
DisclosureSEC source: 0001127602-20-030331 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,851 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.305 to $103.46. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 18:54 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 9,040 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-029815 · form4.xml · derivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,860 Underlying: Common Stock · 9,040 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 18:54 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 9,040 | $101.51 | $917,640.46 |
DisclosureSEC source: 0001127602-20-029815 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,912 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.38 to $101.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 18:54 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 9,040 | $39.87 | $360,424.80 |
DisclosureSEC source: 0001127602-20-029815 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 18:54 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,000 | $101.54 | $507,713.00 |
DisclosureSEC source: 0001127602-20-029815 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,912 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.38 to $101.85. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 6,400 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-029221 · form4.xml · derivative · entry 7 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,900 Underlying: Common Stock · 6,400 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.